Hsa_circ_0101050 accelerates the progression of Colon cancer by targeting the miR-140-3 p/MELK axis.

导出 OA

翻译打印收藏纠错

作者： Kuoju,Cheng ^[1] ; Hao,Chen ^[2] ; Bin,Chen ^[2] ; Jing,Li ^[2] ; Caibo,Fan ^[2] ; Huan,Yan ^[2] ; Wei,Huang ^[2] ; Ting,Zhao ^[2] ; Yun,Luo ^[2] ; Lei,Peng ^[3]

作者单位： Department of Clinical Pharmacy, Dazhou integrated TCM & Western Medicine Hospital, Dazhou 635000, Sichuan, PR China. ^[1] Department of Gastroenterology, Dazhou integrated TCM & Western Medicine Hospital, Dazhou 635000, Sichuan, PR China. ^[2] Department of Gastroenterology, Dazhou integrated TCM & Western Medicine Hospital, Dazhou 635000, Sichuan, PR China. Electronic address: Zfqdc@sina.com. ^[3]

关键词 Circ_0101050 Colon cancer MELK Mir-140–3p

DOI 10.1016/j.tranon.2024.101890

PMID 38579527

发布时间 2024-04-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Translational oncology

2024年44卷

101890页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Hsa_circ_0101050 accelerates the progression of Colon cancer by targeting the miR-140-3 p/MELK axis.

Translational oncology

相似文献

Translational oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Hsa_circ_0101050 accelerates the progression of Colon cancer by targeting the miR-140-3 p/MELK axis.

Translational oncology

相似文献

Translational oncology

相关期刊

检索历史清除